NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Deferiprone

Last Revision: April 20, 2020.

Estimated reading time: 1 minute

CASRN: 30652-11-0

image 134999734 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

Because no information is available on the use of deferiprone during breastfeeding and it is orally absorbed, an alternate drug is preferred, especially while nursing a newborn or preterm infant. Australian guidelines recommend against breastfeeding during deferiprone treatment.[1] The US manufacturer recommends withholding breastfeeding for 2 weeks after the last dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Deferoxamine, Deferasirox

References

1.
Ho PJ, Tay L, Lindeman R, et al. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias. Intern Med J. 2011;41:516–24. [PubMed: 21615659]

Substance Identification

Substance Name

Deferiprone

CAS Registry Number

30652-11-0

Drug Class

Breast Feeding

Lactation

Chelating Agents

Iron Chelating Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Isotretinoin[Drugs and Lactation Database (...]
    Review Isotretinoin
    . Drugs and Lactation Database (LactMed). 2006
  • Review Tolazamide[Drugs and Lactation Database (...]
    Review Tolazamide
    . Drugs and Lactation Database (LactMed). 2006
  • Review Tranylcypromine[Drugs and Lactation Database (...]
    Review Tranylcypromine
    . Drugs and Lactation Database (LactMed). 2006
  • Review Dantrolene[Drugs and Lactation Database (...]
    Review Dantrolene
    . Drugs and Lactation Database (LactMed). 2006
  • Review Droperidol[Drugs and Lactation Database (...]
    Review Droperidol
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...